Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Lansen Pharmaceutical Holdings Limited
  6. News
  7. Summary
    503   KYG5380M1033

LANSEN PHARMACEUTICAL HOLDINGS LIMITED

(503)
  Report
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Lansen Pharmaceutical Holdings Limited Declares Special Dividend, Payable on September 28, 2021

09/16/2021 | 05:05am EDT

Lansen Pharmaceutical Holdings Limited declared a special dividend of HKD 1.55 per share to the shareholders whose names appear in the register of members of the Company on 16 September 2021. The special dividend will be payable on 28 September 2021.


© S&P Capital IQ 2021
All news about LANSEN PHARMACEUTICAL HOLDINGS LIMITED
09/16Lansen Pharmaceutical Holdings Limited Declares Special Dividend, Payable on September ..
CI
09/01LANSEN PHARMACEUTICAL : H1 Profit Declines 98.4% on Lower Skin Disease Treatment Sales
MT
08/31Lansen Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended..
CI
08/31Lansen Pharmaceutical Holdings Limited Declares a Special Dividend, Payable on 28 Septe..
CI
07/29Lansen Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months En..
CI
06/02Lansen Pharmaceutical Holdings Limited commences an Equity Buyback Plan for 39,717,200 ..
CI
04/29LANSEN PHARMACEUTICAL : Form of proxy for use at the annual general meeting to be held on ..
PU
04/29LANSEN PHARMACEUTICAL : Proposal for re-election of directors, general mandates to issue s..
PU
04/16LANSEN PHARMACEUTICAL : Sells Shares Worth $9 Million in Zhejiang Starry Pharma; Lansen Sh..
MT
04/15LANSEN PHARMACEUTICAL : Disposal of starry shares
PU
More news
Financials (USD)
Sales 2020 54,4 M - -
Net income 2020 88,2 M - -
Net cash 2020 83,6 M - -
P/E ratio 2020 1,18x
Yield 2020 -
Capitalization 83,2 M 83,2 M -
EV / Sales 2019 1,52x
EV / Sales 2020 0,37x
Nbr of Employees 627
Free-Float 28,4%
Chart LANSEN PHARMACEUTICAL HOLDINGS LIMITED
Duration : Period :
Lansen Pharmaceutical Holdings Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LANSEN PHARMACEUTICAL HOLDINGS LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Managers and Directors
Li Chen CEO, Executive MD & Non-Executive Director
Zhen Tao Wu Chairman
Kee Huen Chan Independent Non-Executive Director
Fritz Heinrich Horlacher Independent Non-Executive Director
Tak Bun Yeung Independent Non-Executive Director